Prussia

Melting Pot Leverages King of Prussia Mall Success to Launch Hotel-Focused Growth Model

Retrieved on: 
Tuesday, May 23, 2023
Fondue, Prussia, Pot, Growth, King of Prussia (shopping mall), Melting pot, The Melting Pot (restaurant), Hyatt House, Veteran, Tourism, Hotel

TAMPA, Fla., May 23, 2023 /PRNewswire-PRWeb/ -- The strength of sales volume at its King of Prussia Mall location (outside of Philadelphia) located next door to a Hyatt House, has driven CEO Bob Johnston to focus a portion of the brand's future development in or near other hotel properties.

Key Points: 
  • First, if a Melting Pot is the restaurant inside of a hotel, it will bridge that hotel to the community – giving neighbors the ability to experience an unforgettable experience at our restaurant.
  • We are taking both insights and leveraging to expand our franchise growth attention to hoteliers and hotel property owners," he said.
  • For more than 40 years, Melting Pot Restaurants have been providing diners with an experiential meal and hotels have been providing travelers a home with experiential promotions.
  • Within the new design of the Melting Pot Restaurant is two things: an elevated bar experience and a dining experience fit for the traveler.

CHOP and NJIT Researchers Develop New Tool for Studying Multiple Characteristics of a Single Cell

Retrieved on: 
Wednesday, December 21, 2022
Online, Hospital, Protein, NJIT, Philadelphia, U.S. News & World Report, Carnegie Classification of Institutions of Higher Education, Mutation, Cell, RNA, Student, New Jersey Institute of Technology, National Institutes of Health, News, Classification, Children's Hospital of Philadelphia, B cell, Organelle, Spanish National Center for Biotechnology, Health, National Science Foundation, National Center for Advancing Translational Sciences, Gene expression, XSEDE, Prussia, The Princeton Review, CHOP, Center for Applied Genomics, Doctor of Philosophy, TeraGrid, Software, Hakon Hakonarson, Research, Genomics, University, Machine learning, Vaccine, Mobile phone, Management, MD

PHILADELPHIA, Dec. 21, 2022 /PRNewswire/ -- Researchers from Children's Hospital of Philadelphia (CHOP) and New Jersey Institute of Technology (NJIT) developed new software that integrates a variety of information from a single cell, allowing researchers to see how one change in a cell can lead to several others and providing important clues for pinpointing the exact causes of genetic-based diseases.

Key Points: 
  • Single-cell sequencing allows researchers to look at specific aspects of a cell to determine how it interacts with its microenvironment.
  • At the single- cell level, researchers can study gene expression as well as messenger RNA, proteins and even organelles within the cells in much greater detail and resolution than before.
  • The software, referred to as single-cell multimodal deep clustering (scMDC), uses machine learning to analyze data about different characteristics of a single cell.
  • The researchers conducted extensive simulation and real-data experiments and found that scMDC outperformed existing single cell single-modal and multimodal clustering methods on single-cell multimodal data sets.

Children's Hospital of Philadelphia's Congenital Hyperinsulinism Center Celebrates 600 Surgeries

Retrieved on: 
Wednesday, December 21, 2022
Hospital, Surgeon, Diabetes, Patient, Family, History, American Association of Clinical Endocrinologists, Brain, Hypoglycemia, Genetic testing, Disease, Nursing, Children's Hospital of Philadelphia, Hyperinsulinism, Seizure, Diagnosis, Division, Social, Pancreatectomy, Congenital hyperinsulinism, Brain damage, Health, Death, Birth defect, Gene Hatfield, Infant, Pancreas, Prussia, CHOP, Incidence, Insulin, Research, HI, MSCE, Genetics, Health insurance, Pharmaceutical industry, Dentistry, Child, Endocrinology, MD

PHILADELPHIA, Dec. 21, 2022 /PRNewswire/ -- The Congenital Hyperinsulinism (HI) Center at Children's Hospital of Philadelphia (CHOP), the nation's largest and most active center of its kind, is celebrating the completion of 600 pancreatectomies, a surgical procedure that involves removing all or part of the pancreas. The procedure is used to treat some forms of congenital HI, a life-threatening genetic disorder in which the insulin cells of the pancreas, called beta cells, secrete too much insulin, leading to low blood sugar (hypoglycemia).

Key Points: 
  • PHILADELPHIA, Dec. 21, 2022 /PRNewswire/ -- The Congenital Hyperinsulinism (HI) Center at Children's Hospital of Philadelphia (CHOP), the nation's largest and most active center of its kind, is celebrating the completion of 600 pancreatectomies, a surgical procedure that involves removing all or part of the pancreas.
  • Established in 1998, CHOP's HI Center treats children with congenital HI from all over the world.
  • The multidisciplinary team in CHOP's HI Center works together to provide specialized, patient-centered care for children with congenital HI and their families.
  • About Children's Hospital of Philadelphia: A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

Children's Hospital of Philadelphia's Healthier Together Initiative Awards $225,000 to Nine Community-based Organizations Delivering Violence-Prevention Programs

Retrieved on: 
Monday, December 12, 2022
Prussia, City, Housing, Partners for Community Impact, Government, Poverty, Partnership, Health, Delaware Valley, Hunger, Research, Assistant, Child, Trauma, Children's Hospital of Philadelphia, CHOP, Hospital, Violence, Community, Homeland Security Grant Program, CDC, AFRICOM, Welcome Home (Zac Brown Band album), Medicine, Drug, Policy

The grant is part of Healthier Together's existing GRIT program , which provides trauma support services to children and families through CHOP Primary Care and after-school programs.

Key Points: 
  • The grant is part of Healthier Together's existing GRIT program , which provides trauma support services to children and families through CHOP Primary Care and after-school programs.
  • "The GRIT Grant Program will bolster the effectiveness of these nine community-based organizations by providing the resources to deliver more impactful violence-prevention programming for youth."
  • Healthier Together partners with community groups, nonprofits, and government agencies to learn from each other and multiply our collective impact.
  • About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

Children's Hospital of Philadelphia Celebrates 5,000 Deliveries in Garbose Family Special Delivery Unit

Retrieved on: 
Wednesday, November 30, 2022
Growth, Fetus, Children's Hospital of Philadelphia, Diagnosis, SCT, Electrical telegraph, Gastroschisis, Ventricular septal defect, Hospital, Mother, Garbose Building, Non-functional testing, Health, Physician, CGC, Neoplasm, Omphalocele, Spina bifida, Birth, Parent, Prussia, Congenital diaphragmatic hernia, Harriet, Hydrops, CFDT, Birth defect, Research, Delivery unit, SDU, CHOP, Woman, Surgeon, Sacrococcygeal teratoma, Dentistry, Toy, Medical imaging, MD, Child, Lyra, Treatment

PHILADELPHIA, Nov. 30, 2022 /PRNewswire/ -- More than 14 years after opening the Garbose Family Special Delivery Unit (SDU), the world's first birth facility exclusively for mothers carrying babies with known birth defects, Children's Hospital of Philadelphia (CHOP) is celebrating its 5,000th delivery.

Key Points: 
  • PHILADELPHIA, Nov. 30, 2022 /PRNewswire/ -- More than 14 years after opening the Garbose Family Special Delivery Unit (SDU), the world's first birth facility exclusively for mothers carrying babies with known birth defects, Children's Hospital of Philadelphia (CHOP) is celebrating its 5,000th delivery.
  • "Traditionally, these mothers will give birth in one hospital, and their newborn will be transferred to a specialized pediatric hospital shortly after delivery.
  • "The Garbose Special Delivery Unit is a very important part of the comprehensive care our Center for Fetal Diagnosis and Treatment is able to provide."
  • About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.

CHOP-led Study Shows that Antibiotic-Resistant Microbes in the Gut Make C. difficile More Infectious

Retrieved on: 
Wednesday, November 16, 2022
Health, Doctor of Philosophy, University of Minnesota Medical School, Philadelphia, Hospital, Clostridioides difficile infection, RNA, IBD, Infection, VRE, Prussia, University of Virginia, Environment, Collection, Metabolomics, Clostridioides difficile (bacteria), University, Vancomycin-resistant Enterococcus, Vanderbilt University School of Medicine, Assistant, Ornithine, Pathology, Research, Association, Organic acid, Patient, Nutrient, Inflammatory bowel disease, University of Florida, University of Pittsburgh, Children's Hospital of Philadelphia, DOI, Medical laboratory, Virulence, Arginine, Gastrointestinal tract, CHOP, Public health, Dietary supplement, Pharmaceutical industry, Nature, Child, Enterococcus

PHILADELPHIA, Nov. 16, 2022 /PRNewswire/ -- Clostridioides difficile, often referred to as C. difficile or C. diff, is a bacterium that causes severe intestinal illness and, as its name suggests, can be difficult to study and treat. Approximately 1 in 6 patients infected with C. difficile will be reinfected within two months. Yet scientists have not figured out why C. difficile infection is more difficult to treat in some patients versus others. The human gut is filled with trillions of microbes, and these microbes influence the virulence of various pathogens, but until now, scientists had little understanding of how C. difficile cooperates with the rich collection of microorganisms in the gastrointestinal tract.

Key Points: 
  • Yet scientists have not figured out why C. difficile infection is more difficult to treat in some patients versus others.
  • Prior studies have shown that adults infected with C. difficile also have high levels of Enterococcus in their gut and that vancomycin-resistant Enterococcus (VRE) frequently co-infects patients with C. difficile.
  • They also observed a positive correlation between C. difficile burdens and ornithine, supporting a key role for this amino acid in C. difficile infection.
  • difficile."

CHOP Researchers Find Financial Strain Due to COVID-19 Pandemic Took Significant Toll on Adolescent Mental Health

Retrieved on: 
Tuesday, November 15, 2022
People, Health, Doctor of Philosophy, Philadelphia, Hospital, ABCD Study, Perelman School of Medicine at the University of Pennsylvania, Prussia, Adolescence, Malapatan, St. Louis Fed Financial Stress Index, Income, Interpersonal relationship, Mental health, Mechanics, Research, Association, COVID-19, Grammatical mood, Children's Hospital of Philadelphia, DOI, CHOP, Public health, Pharmaceutical industry, Medicine, Restaurant, MD, Child

PHILADELPHIA, Nov. 15, 2022 /PRNewswire/ -- Financial stress due to the COVID-19 pandemic took a distinct toll on adolescent mental health and contributed to depressive symptoms, according to a new study by researchers at Children's Hospital of Philadelphia (CHOP). The study, published today in The Lancet Regional Health – Americas, found the effect was most pronounced in low-income adolescents but also affected all income groups who experienced financial strain due to loss of income.

Key Points: 
  • However, despite an ongoing global youth mental health crisis, there previously was little data on the impact of financial stress on adolescent mental health.
  • The researchers investigated the specific association of financial strain with adolescent mental health between May 2020 and May 2021.
  • "Future studies should look at targeting youth's financial stress and family conflict to ease the mental health impact of difficult financial circumstances."
  • "COVID-19-related financial strain and adolescent mental health," The Lancet Regional Health Americas, November 15, 2022, DOI: https://doi.org/10.1016/j.lana.2022.100391 .

AirSculpt® Technologies, Inc. Announces Openings of Centers in Philadelphia and Boston

Retrieved on: 
Tuesday, November 8, 2022
GLOBE, MAK Technologies, Inc., Prussia, King of Prussia (shopping mall), Suite, NASDAQ, England, United States Capitol, MIAMI, Skin, Patient, Bruise

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at Elite Body Sculpture offices.

Key Points: 
  • AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at Elite Body Sculpture offices.
  • Were thrilled to announce the opening of our Philadelphia and Boston centers, said Dr. Aaron Rollins, Founder and Chief Executive Officer at AirSculpt Technologies.
  • Our continued expansion speaks to the growing demand for our patented AirSculpt technology and we are pleased to offer our premium experience to the Philadelphia and Boston markets.
  • More than 30,000 AirSculpt cases have been performed in AirSculpt Technologies premium locations throughout the U.S. For additional information about scheduling a virtual or in-person consultation at any of the 21 centers, visit elitebodysculpture.com .

CHOP Researchers Find COVID-19 Vaccination Leads to Higher Antibody Levels than Natural Infection in Both Pregnant People and their Babies

Retrieved on: 
Wednesday, November 9, 2022
Assistant, Diabetes, Hospital, Hypertension, Vaccination, Antibody, Immunoglobulin G, Patient, University, Vaccine, Infection, CHOP, RNA transfection, Obesity, Pregnancy, Philadelphia, DO, COVID-19, MSCE, JAMA Network Open, DOI, Doctor of Philosophy, Children's Hospital of Philadelphia, Mother, Pediatrics, Efficiency, Pennsylvania Hospital, Gestational age, Comparison, Research, Severe acute respiratory syndrome coronavirus 2, Health, Prussia, Time, Microbiology, Child

PHILADELPHIA, Nov. 9, 2022 /PRNewswire/ --Pregnant people who received one of the mRNA COVID-19 vaccines had 10-fold higher antibody concentrations than those who were naturally infected with SARS-CoV-2, a finding that was also observed in their babies, according to a new study by researchers at Children's Hospital of Philadelphia (CHOP) and the University of Pennsylvania. The study, published today in JAMA Network Open, also found that vaccine timing played an important role in maximizing the transfer of antibodies, with antibodies detected as early as 15 days after the first vaccine dose and increasing for several weeks after.

Key Points: 
  • "Given that pregnancy is a risk factor for severe COVID-19, this study suggests pregnant people should prioritize getting vaccinated to protect themselves and their babies."
  • In collaboration with CHOP researchers, his laboratory evaluated cord blood serum from 585 pregnant people who had detectable SARS-CoV-2 antibodies.
  • They found that antibody levels among vaccine recipients were approximately 10-times higher than in people who had been naturally infected.
  • Of those newborns with detectable antibodies, the researchers found that levels were 10-times higher in the vaccinated group than in the naturally infected group.

Children's Hospital of Philadelphia Joins Forces with Gilbane Building Company, Pride Enterprises, and McKissack & McKissack to Create State-of-the-Art Pediatric Research Building

Retrieved on: 
Thursday, October 13, 2022
Time, Coffeehouse, Commerce, Gilbane Building Company, Life, Hospital, Growth, South Street Bridge (Philadelphia, Pennsylvania), Navy Yard, McKissack, Pediatric Research, Research, Workforce, Prussia, Construction, McKissack & McKissack, Children's Hospital of Philadelphia, Senior, CHOP, Sport, General contractor, Industry, Health, Ownership, Gilbane, Inc., Safety, Environment, City, Government, Real estate, PAGE, Center, Roberts Center, Medicine, Retail, Interior design, Child, Pride

PHILADELPHIA, Oct. 13, 2022 /PRNewswire/ -- In an effort to create the pediatric research building of the future, Children's Hospital of Philadelphia (CHOP) has joined forces with Gilbane Building Company, Pride Enterprises, and McKissack & McKissack to construct the Schuylkill Avenue Research Building. The tri-venture Gilbane/Pride/McKissack will provide construction management services to build a state-of-the-art research facility, where researchers from different disciplines can collaborate and make discoveries that will define the next century of pediatric healthcare.  

Key Points: 
  • PHILADELPHIA, Oct. 13, 2022 /PRNewswire/ -- In an effort to create the pediatric research building of the future, Children's Hospital of Philadelphia (CHOP) has joined forces with Gilbane Building Company , Pride Enterprises , and McKissack & McKissack to construct the Schuylkill Avenue Research Building.
  • Situated next to the Roberts Center for Pediatric Research, the new 14-story, 350,000-square-foot building will have many spaces designed to encourage scientific collaboration.
  • About Children's Hospital of Philadelphia:A non-profit, charitable organization, Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediatric hospital.
  • McKissack has offices in New York and Philadelphia, as well as regional offices across the country including Boston and North Carolina.